CG
MIRM icon

Caprock Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Caprock Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Buy
3,435
+401
+13% +$40.3K 0.01% 929
2026
Q1 		$280K Sell
3,034
-2,563
-46% -$241K 0.01% 948
2025
Q4 		$442K Buy
5,597
+819
+17% +$58.8K 0.01% 866
2025
Q3 		$353K Buy
+4,778
New +$304K 0.01% 899

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caprock Group's MIRM Position: Q2 2026 in Review

Caprock Group increased its Mirum Pharmaceuticals (MIRM) stake by 13% in Q2 2026, buying an estimated $40.3K and bringing the position to 3,435 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #929.

Caprock Group first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. The position peaked at $442K in Q4 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Caprock Group held 3,435 shares of Mirum Pharmaceuticals worth $402K as of Q2 2026.
  • Caprock Group bought 401 Mirum Pharmaceuticals shares in Q2 2026, an estimated $40.3K.
  • Mirum Pharmaceuticals made up 0.01% of Caprock Group's portfolio in Q2 2026, its #929 holding.
  • Caprock Group first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Caprock Group's Mirum Pharmaceuticals position peaked at $442K in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.